Predictive values of novel high‑density lipoprotein‑related inflammatory indices in in‑stent restenosis among patients undergoing elective percutaneous coronary intervention-Reference-Cited by-同舟云学术

Predictive values of novel high‑density lipoprotein‑related inflammatory indices in in‑stent restenosis among patients undergoing elective percutaneous coronary intervention

Published:2023-12-13 Issue:2 Volume:27 Page:
ISSN:1792-0981
Container-title:Experimental and Therapeutic Medicine
language:
Short-container-title:Exp Ther Med

Author:

Guo Xuantong¹,Shen Ruihuan²,Lu Peipei¹,Ma Lihong¹

Affiliation:

1. State Key Laboratory of Cardiovascular Disease, Department of Cardiology, National Clinical Research Center of Cardiovascular Diseases, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, P.R. China

2. Department of Cardiology, National Center of Gerontology, Institute of Geriatric Medicine, Beijing Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine

Reference41 articles.

1. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: A report of the American college of cardiology/American heart association joint committee on clinical practice guidelines;Lawton;Circulation,2022

2. Initial invasive or conservative strategy for stable coronary disease;Maron;N Engl J Med,2020

3. Management of in-stent restenosis;Alfonso;EuroIntervention,2022

4. Restenosis of drug-eluting stents: A new classification system based on disease mechanism to guide treatment and state-of-the-art review;Shlofmitz;Circ Cardiovasc Interv,2019

5. Report on cardiovascular health and diseases in China 2021: An updated summary;Chin Circ J,2022